These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24753171)

  • 1. A proposal to reduce contrast nephropathy: eliminate the NPO order.
    Bittl JA
    Catheter Cardiovasc Interv; 2014 May; 83(6):913-4. PubMed ID: 24753171
    [No Abstract]   [Full Text] [Related]  

  • 2. Volume-to-creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: implications of varying definitions of contrast-induced nephropathy.
    Capodanno D; Ministeri M; Cumbo S; Dalessandro V; Tamburino C
    Catheter Cardiovasc Interv; 2014 May; 83(6):907-12. PubMed ID: 23934631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of contrast media on kidney function in patients with stable coronary artery disease.
    Reuter SB; Harutyunyan M; Mygind ND; Jørgensen E; Kastrup J
    Scand Cardiovasc J; 2014 Aug; 48(4):234-40. PubMed ID: 24941300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of persistent renal dysfunction after contrast enhanced coronary CT angiography in patients with suspected coronary artery disease.
    Maaniitty T; Stenström I; Uusitalo V; Ukkonen H; Kajander S; Bax JJ; Saraste A; Knuuti J
    Int J Cardiovasc Imaging; 2016 Oct; 32(10):1567-75. PubMed ID: 27405562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous intervention.
    Barbieri L; Verdoia M; Marino P; Suryapranata H; De Luca G;
    Eur J Prev Cardiol; 2016 Jun; 23(9):931-7. PubMed ID: 26525064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated homocysteine and the risk of contrast-induced nephropathy: a cohort study.
    Barbieri L; Verdoia M; Schaffer A; Niccoli G; Perrone-Filardi P; Bellomo G; Marino P; Suryapranata H; Luca GD
    Angiology; 2015 Apr; 66(4):333-8. PubMed ID: 24830422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Kurtul A; Yarlioglues M; Murat SN; Demircelik MB; Acikgoz SK; Ergun G; Duran M; Cetin M; Ornek E
    Angiology; 2015 May; 66(5):433-40. PubMed ID: 24834929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased aortic stiffness predicts contrast-induced nephropathy in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
    Uçar H; Gür M; Yildirim A; Börekçi A; Gözükara MY; Seker T; Kaypakli O; Türkoğlu C; Özaltun B; Akyol S; Harbalioğlu H; Sahin DY; Elbasan Z; Çayli M
    Angiology; 2014 Oct; 65(9):806-11. PubMed ID: 24078516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Percutaneous transluminal coronary angioplasty, x-ray contrast researches and contrast-induced nephropathy in geriatrics].
    Ar'ev AL; Chesnokov AA
    Adv Gerontol; 2013; 26(3):511-7. PubMed ID: 24640703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin Resistance Increases the Risk of Contrast-Induced Nephropathy in Patients Undergoing Elective Coronary Intervention.
    Li Y; Liu Y; Shi D; Yang L; Liang J; Zhou Y
    Angiology; 2016 Feb; 67(2):139-45. PubMed ID: 25843952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-to-lymphocyte ratio predicts contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention.
    Kaya A; Kurt M; Tanboğa IH
    Angiology; 2014 Jan; 65(1):59. PubMed ID: 24052523
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
    Chen Y; Hu S; Liu Y; Zhao R; Wang L; Fu G; He Q; Su X; Zheng Y; Qi X; Liu H; Wang J; Gao W; Wang M; Liu S; Zheng X; He B; Yang P; Zhou S; Gao C; Qiu C
    EuroIntervention; 2012 Nov; 8(7):830-8. PubMed ID: 23045301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary renalase concentration in patients with preserved kidney function undergoing coronary angiography.
    Wybraniec MT; Bożentowicz-Wikarek M; Chudek J; Mizia-Stec K
    Nephrology (Carlton); 2018 Feb; 23(2):133-138. PubMed ID: 27778420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete Versus Culprit-Only Revascularization for Patients With Multi-Vessel Disease Undergoing Primary Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Trials.
    Elgendy IY; Wen X; Mahmoud A; Bavry AA
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):501-505. PubMed ID: 26524970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-to-lymphocyte ratio may predict contrast-induced nephropathy.
    Demirkol S; Balta S; Kucuk U; Karaman M; Kucuk HO; Kurt O
    Angiology; 2014 Jan; 65(1):57-8. PubMed ID: 23716724
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of radiological risk during coronary angioplasty procedures: comparison of transradial and transfemoral approaches.
    Iwachow P; Miechowicz I; Kałmucki P; Dziki B; Szyszka A; Baszko A; Siminiak T
    Int J Cardiovasc Imaging; 2017 Sep; 33(9):1297-1303. PubMed ID: 28364175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivessel percutaneous coronary intervention without contrast agents.
    Vidi VD; Barseghian A; Garratt KN
    Catheter Cardiovasc Interv; 2016 Dec; 88(7):E222-E226. PubMed ID: 26708315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Transient or Persistent Contrast-induced Nephropathy on Long-term Mortality After Elective Percutaneous Coronary Intervention.
    Abe M; Morimoto T; Nakagawa Y; Furukawa Y; Ono K; Kato T; Kadota K; Ando K; Ishii M; Masunaga N; Akao M; Kimura T
    Am J Cardiol; 2017 Dec; 120(12):2146-2153. PubMed ID: 29106836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.